- Home
- LYEL vs TCMD Comparison
LYEL vs TCMD Comparison
Compare LYEL & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- TCMD
- Stock Information
- Founded
- LYEL 2018
- TCMD 1995
- Country
- LYEL United States
- TCMD United States
- Employees
- LYEL N/A
- TCMD N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- LYEL Health Care
- TCMD Health Care
- Exchange
- LYEL Nasdaq
- TCMD Nasdaq
- Market Cap
- LYEL 207.7M
- TCMD 235.5M
- IPO Year
- LYEL 2021
- TCMD 2016
- Fundamental
- Price
- LYEL $11.02
- TCMD $9.65
- Analyst Decision
- LYEL Sell
- TCMD Hold
- Analyst Count
- LYEL 2
- TCMD 3
- Target Price
- LYEL $15.00
- TCMD $16.00
- AVG Volume (30 Days)
- LYEL 72.8K
- TCMD 181.4K
- Earning Date
- LYEL 08-11-2025
- TCMD 08-04-2025
- Dividend Yield
- LYEL N/A
- TCMD N/A
- EPS Growth
- LYEL N/A
- TCMD N/A
- EPS
- LYEL N/A
- TCMD 0.66
- Revenue
- LYEL $65,000.00
- TCMD $293,164,000.00
- Revenue This Year
- LYEL N/A
- TCMD $7.96
- Revenue Next Year
- LYEL N/A
- TCMD $8.53
- P/E Ratio
- LYEL N/A
- TCMD $14.62
- Revenue Growth
- LYEL N/A
- TCMD 5.96
- 52 Week Low
- LYEL $7.65
- TCMD $8.61
- 52 Week High
- LYEL $32.60
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- LYEL 52.37
- TCMD 41.70
- Support Level
- LYEL $9.11
- TCMD $10.09
- Resistance Level
- LYEL $14.18
- TCMD $10.76
- Average True Range (ATR)
- LYEL 0.94
- TCMD 0.40
- MACD
- LYEL 0.15
- TCMD -0.01
- Stochastic Oscillator
- LYEL 38.68
- TCMD 17.54
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.